Franco-German group AVENTIS has decided to outsource some of its clinical research activities in Germany through a joint venture with the British risk capital firm 3I. No financial details have been given - the deal covers an AVENTIS PHARMA laboratory in Frankfurt. The holding company for the lab is called COVIDENCE - some 40% of it is held by AVENTIS, 30% by 3I and 30% by staff and managers.